Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2012 May 1;30(13):1422-8.
doi: 10.1200/JCO.2010.34.3467. Epub 2011 Sep 6.

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children

Henk Visscher  1 , Colin J D Ross, S Rod Rassekh, Amina Barhdadi, Marie-Pierre Dubé, Hesham Al-Saloos, George S Sandor, Huib N Caron, Elvira C van Dalen, Leontien C Kremer, Helena J van der Pal, Andrew M K Brown, Paul C Rogers, Michael S Phillips, Michael J Rieder, Bruce C Carleton, Michael R Hayden; Canadian Pharmacogenomics Network for Drug Safety Consortium
Collaborators, Affiliations
Multicenter Study

Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children

Henk Visscher et al. J Clin Oncol. .

Abstract

Purpose: Anthracycline-induced cardiotoxicity (ACT) is a serious adverse drug reaction limiting anthracycline use and causing substantial morbidity and mortality. Our aim was to identify genetic variants associated with ACT in patients treated for childhood cancer.

Patients and methods: We carried out a study of 2,977 single-nucleotide polymorphisms (SNPs) in 220 key drug biotransformation genes in a discovery cohort of 156 anthracycline-treated children from British Columbia, with replication in a second cohort of 188 children from across Canada and further replication of the top SNP in a third cohort of 96 patients from Amsterdam, the Netherlands.

Results: We identified a highly significant association of a synonymous coding variant rs7853758 (L461L) within the SLC28A3 gene with ACT (odds ratio, 0.35; P = 1.8 × 10(-5) for all cohorts combined). Additional associations (P < .01) with risk and protective variants in other genes including SLC28A1 and several adenosine triphosphate-binding cassette transporters (ABCB1, ABCB4, and ABCC1) were present. We further explored combining multiple variants into a single-prediction model together with clinical risk factors and classification of patients into three risk groups. In the high-risk group, 75% of patients were accurately predicted to develop ACT, with 36% developing this within the first year alone, whereas in the low-risk group, 96% of patients were accurately predicted not to develop ACT.

Conclusion: We have identified multiple genetic variants in SLC28A3 and other genes associated with ACT. Combined with clinical risk factors, genetic risk profiling might be used to identify high-risk patients who can then be provided with safer treatment options.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

LinkOut - more resources